Histone cluster 1 H2BM Inhibitors form a distinctive class of chemical compounds designed to selectively impede the activity of histone cluster 1, with a specific emphasis on the H2BM subtype. Histones are essential proteins orchestrating the organization of DNA within the nucleus, forming nucleosomes that constitute the structural framework for chromatin. The H2BM designation refers to a variant of histone H2B, a core histone pivotal for nucleosome assembly. The H2B family of histones plays a central role in regulating gene expression and modulating chromatin architecture. Inhibitors developed for Histone cluster 1 H2BM are intricately engineered to interact with specific regions of this histone variant, potentially influencing its binding to DNA and other proteins, thereby modulating chromatin dynamics.
The development of Histone cluster 1 H2BM Inhibitors requires a profound understanding of the structural characteristics of histone H2BM and its specific role within chromatin organization. These inhibitors are designed for specificity, aiming to selectively bind to key regions of Histone cluster 1 H2BM and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can delve into the consequences of inhibiting this particular histone variant, providing valuable insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H2BM, significantly contributes to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid is a histone deacetylase inhibitor, altering chromatin structure and potentially impacting the acetylation status of histones, including H2BM. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 inhibits lysine demethylase, potentially influencing histone demethylation and the transcriptional regulation of genes, including H2BM. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H2BM. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is a histone deacetylase inhibitor, impacting chromatin structure and potentially affecting the acetylation status of histones, including H2BM. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 targets the methyltransferase activity of histone methyltransferase, possibly impacting the methylation status and expression of H2BM. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a potent histone deacetylase inhibitor, influencing gene expression by maintaining acetylation levels on histones, including H2BM. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including Histone cluster 1 H2BM. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor, disrupting interactions between bromodomain proteins and acetylated histones, potentially influencing gene expression, including H2BM. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H2BM. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2BM. | ||||||